We have previously shown that the angiogenic inducer, cysteine-rich, angiogenic inducer, 61 (CYR61), is highly expressed in the day 4 bovine corpus luteum (CL). Along with some of the known angiogenic regulators, vascular endothelial growth factor A (VEGF), fibroblast growth factor 2 (FGF2) and matrix metalloproteinase 2 (MMP2), CYR61 may function to promote the high rate of angiogenesis that occurs during the early development of the CL. Since the folliculo-luteal transition results in the infiltration of blood vessels from the vascularized theca interna into the avascular granulosa compartment, we hypothesized that CYR61 may play a critical role in switching on this angiogenic process. However, because it is not known whether ovarian follicles or the surrounding stroma may also synthesize CYR61, our objectives were to determine the expression of CYR61 in bovine granulosa and theca, and relate its expression to know angiogenic regulators such as VEGF, FGF2 and MMP2. Ovaries were removed from midcycle Holstein cows at time 0 (control, no treatment) and at 24 hours or 48 hours following prostaglandin F2 alpha (PGFa) injection. Dissected follicles were measured (diameter; mm); follicular fluid was aspirated; and the granulosa cells and theca interna were separated before RNA was extracted from them. cDNAs generated from granulosa cells and theca interna were analyzed by quantitative PCR to determine the levels of known angiogenic factors, including CYR61, VEGF, FGF and MMP2. Additionally, follicular fluid was analyzed for expression and activity of MMP2 and MMP9 by zymography. Follicular fluid estradiol (E2) and progesterone (P4) concentrations were determined by radioimmunoassay to assess the health status of follicles. The E2 concentrations in the follicular fluid obtained from the largest follicles (diameter 18.9 mm to 22.4 mm) were high, indicating that they were healthy. In addition, plasma P4 concentrations decreased accordingly following PGF2a injection. Further, although there were no differences in mRNA expression of selected angiogenic factors between follicles of PGF2a treated and control cows for any of the endpoints, the mRNA expression of CYR61, FGF2 and MMP2 was always higher (p<0.05) in the thecal than in the granulosa compartment within controls and within each treatment group. In contrast, the mRNA expression of VEGF in the thecal compartment was always lower (p<0.05) than in the hypoxic, granulosa compartment within controls and each treatment group. In summary, CYR61 is reported, for the first time, to be expressed in vivo by granulosa cells and theca interna of bovine ovarian follicles. The function of CYR61 and other angiogenic regulators in the folliculo-luteal transition remains to be elucidated, awaiting analysis of follicles collected at earlier time points, e.g. at 1, 6 and 12 hrs following PGFa injection. This research was supported in part by: NIH grant P01 CA045548 to MAM and by the Multistate Northeast Regional Project NE-1027 to PCWT. (poster)
Read full abstract